Rezolute
Clinical trials sponsored by Rezolute, explained in plain language.
-
New drug aims to tame tumor-triggered low blood sugar in rare cancer patients
Disease control Recruiting nowThis study tests a new medicine called ersodetug for people whose tumors cause dangerously low blood sugar that standard treatments can't control. About 16 adults with insulin-producing tumors will receive the drug alongside their usual care. The main goal is to see if ersodetug …
Phase: PHASE3 • Sponsor: Rezolute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug access for rare Tumor-Induced low blood sugar
Disease control AVAILABLEThis program provides an investigational drug, ersodetug, to people with dangerously low blood sugar caused by certain tumors. It is for those who cannot join a formal clinical trial. The goal is to help control blood sugar levels when standard treatments are not enough.
Sponsor: Rezolute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC